IMRA
Price:
$6.32
Market Cap:
$165.80M
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas. IMARA Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Industry
Biotechnology
IPO Date
2020-03-12
Stock Exchange
NASDAQ
Ticker
IMRA
According to IMARA Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 105.33. This represents a change of -6311.68% compared to the average of -1.70 of the last 4 quarters.
The mean historical PE Ratio of IMARA Inc. over the last ten years is 0.18. The current 105.33 PE Ratio has changed 5.88% with respect to the historical average. Over the past ten years (40 quarters), IMRA's PE Ratio was at its highest in in the December 2022 quarter at 0.21. The PE Ratio was at its lowest in in the June 2020 quarter at -11.64.
Average
0.18
Median
-1.55
Minimum
-12.50
Maximum
17.06
Discovering the peaks and valleys of IMARA Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 21.35%
Maximum Annual PE Ratio = 17.06
Minimum Annual Increase = -7259.73%
Minimum Annual PE Ratio = -12.50
Year | PE Ratio | Change |
---|---|---|
2022 | 17.06 | -7259.73% |
2021 | -0.24 | -87.31% |
2020 | -1.88 | 21.35% |
2019 | -1.55 | -87.62% |
The current PE Ratio of IMARA Inc. (IMRA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
4.98
5-year avg
0.18
10-year avg
0.18
IMARA Inc.’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IMARA Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like IMARA Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is IMARA Inc.'s PE Ratio?
How is the PE Ratio calculated for IMARA Inc. (IMRA)?
What is the highest PE Ratio for IMARA Inc. (IMRA)?
What is the 3-year average PE Ratio for IMARA Inc. (IMRA)?
What is the 5-year average PE Ratio for IMARA Inc. (IMRA)?
How does the current PE Ratio for IMARA Inc. (IMRA) compare to its historical average?